Profile: Thermosurgery Technologies, Inc. (TTI) is a medical device company. Our TTI treatment utilizes radio frequency to generate heat within tissue. Abnormal and diseased cells cannot tolerate the heat and the cells die. The surrounding healthy cells are not affected because the temperature is within a tolerable range. In addition to the death of the unwanted cells, the immune system is provoked and promotes in the healing of the treated area. Our treatment is ideal for acrochordon, actinic keratoses, angioma, atypical mycobacteria, clavus, cystic acne, dermatophytosis, epidermoid cysts, fibroma, human papillomavirus - HPV/warts, hydrocystoma, keloids, cutaneous leishmaniasis, molluscum contagiosum, seborrheic keratoses, basal cell carcinoma - skin cancer and syringoma. Our ThermoMed™ model 1.8 device is used in the treatment of basal cell carcinoma.

The company was founded in 1990, has revenues of < USD 1 Million and is ISO, CE certified.

FDA Registration Number: 2027460